Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 2Lymphoma, B-Cell 2Carcinoma, Transitional Cell 2Carcinoma 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Lung Neoplasms 1Liposarcoma, Myxoid 1Leukemia, Myeloid, Acute 1Endometrial Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 3fludarabine 2selinexor 1pembrolizumab 1pazopanib 1palbociclib 1mirdametinib 1fludarabine phosphate 1X-Rays 1Specimen Handling 1Radiation 1Proton Therapy 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Ifosfamide 1Doxorubicin 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma, Myxoid × ALT-803 × 90 days × Clear all
NCT07261657 2026-05-05

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Northwestern University

Phase EARLY_PHASE1 Recruiting
8 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡